Growth Metrics

Humana (HUM) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Humana (HUM) over the last 17 years, with Q3 2025 value amounting to 1.81%.

  • Humana's EBITDA Margin fell 14400.0% to 1.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.99%, marking a year-over-year decrease of 1900.0%. This contributed to the annual value of 2.95% for FY2024, which is 16200.0% down from last year.
  • Per Humana's latest filing, its EBITDA Margin stood at 1.81% for Q3 2025, which was down 14400.0% from 4.0% recorded in Q2 2025.
  • In the past 5 years, Humana's EBITDA Margin registered a high of 7.18% during Q1 2023, and its lowest value of 1.09% during Q4 2024.
  • Its 5-year average for EBITDA Margin is 4.23%, with a median of 4.94% in 2024.
  • The largest annual percentage gain for Humana's EBITDA Margin in the last 5 years was 22000bps (2021), contrasted with its biggest fall of -66900bps (2021).
  • Quarter analysis of 5 years shows Humana's EBITDA Margin stood at 1.11% in 2021, then rose by 28bps to 1.42% in 2022, then plummeted by -134bps to 0.48% in 2023, then crashed by -128bps to 1.09% in 2024, then surged by 267bps to 1.81% in 2025.
  • Its last three reported values are 1.81% in Q3 2025, 4.0% for Q2 2025, and 6.89% during Q1 2025.